Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer

BACKGROUND: This study evaluated the efficacy and safety of docetaxel combined with lobaplatin, relative to docetaxel combined with gemcitabine, for treating patients with recurrent metastatic breast cancer (rMBC). METHODS: Patients with rMBC received ≥2 cycles (21 days each) of either docetaxel and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Li, Fenghu, Wang, Bi, He, Mingyuan, Chang, Jianying, Li, Jiehui, Shan, Lang, Wang, Heran, Hong, Wei, Luo, Daiqin, Song, Yang, Liu, Liyang, Li, Huiqin, Ran, Li, Chen, Tengxiang
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2019
Assuntos:
4200
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946339/
https://ncbi.nlm.nih.gov/pubmed/31876741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000018513
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados